Whittier Trust
KYMR icon

Whittier Trust’s Kymera Therapeutics KYMR Stock Holding History

Whittier Trust’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.6K Hold
183
– – ﹤0.01% 1023
2026
Q2 		$21K Hold
183
– – ﹤0.01% 1021
2026
Q1 		$15.6K Hold
183
– – ﹤0.01% 1053
2025
Q4 		$13.4K Hold
183
– – ﹤0.01% 1094
2025
Q3 		$10.6K Buy
+183
New +$8.25K ﹤0.01% 1112
2021
Q2 		– Sell
-1,000
Closed -$39K – 1542
2021
Q1 		$39K Hold
1,000
– – ﹤0.01% 990
2020
Q4 		$62K Hold
1,000
– – ﹤0.01% 808
2020
Q3 		$32K Buy
+1,000
New +$30.5K ﹤0.01% 915

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Whittier Trust's KYMR Position: Q3 2026 in Review

Whittier Trust held its Kymera Therapeutics (KYMR) position steady in Q3 2026 at 183 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Whittier Trust first reported a position in KYMR in Q3 2020 and has held it in 8 quarters since. The position peaked at $62K in Q4 2020. 215 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Whittier Trust held 183 shares of Kymera Therapeutics worth $20.6K as of Q3 2026.
  • Whittier Trust left its Kymera Therapeutics share count unchanged in Q3 2026.
  • Kymera Therapeutics made up ﹤0.01% of Whittier Trust's portfolio in Q3 2026, its #1023 holding.
  • Whittier Trust first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 8 quarters since.
  • Whittier Trust's Kymera Therapeutics position peaked at $62K in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Whittier Trust's 13F filing for Q3 2026, filed 12 Nov 2026.